I found Bijal Shah’s analysis regarding Azer-cel as quite frank...

I found Bijal Shah’s analysis regarding Azer-cel as quite frank in his presentation of both the good and the bad. My understanding of the science behind it is limited to my ability to digest and understand it from a layperson’s perspective/skills set. I get there is some great stuff going on but is a work in progress.

From what I have gleaned by comparing these audio/video linked presentations by both Bijal Shah and Saul Priceman, is that the results presented mirror somewhat the diluted version Imugene released on 30 May in their poster presentation. Does anyone disagree?

I note however, that the concern about toxicity by Bijal Shah is not highlighted in Imugene’s poster, though Bijal did give an indication the situation is an ongoing concern. One would assume those conducting the studies / trials would continue to analyse and tweek any drug combinations in combatting the toxicity aspects, and further results and data would inevitably follow.

Maybe those with the ability to break the science down further for us might have input? Dare I ask @Mason14, any input / your take?

Thoughts anyone else?